SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-133851
Filing Date
2016-07-25
Accepted
2016-07-25 17:08:44
Documents
1
Period of Report
2016-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 33612
  Complete submission text file 0001209191-16-133851.txt   35230
Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104 650-233-2211
Versant Ventures IV, LLC (Reporting) CIK: 0001456589 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37833 | Film No.: 161782622

Mailing Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2650 SAN FRANCISCO CA 94104 415-638-6556
Audentes Therapeutics, Inc. (Issuer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)